Corient Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$1.11M Buy
6,625
+462
+7% +$77.6K 0.08% 202
2022
Q2
$1.04M Sell
6,163
-993
-14% -$167K 0.08% 220
2022
Q1
$1.79M Buy
7,156
+1,009
+16% +$253K 0.12% 157
2021
Q4
$1.58M Buy
6,147
+28
+0.5% +$7.2K 0.1% 173
2021
Q3
$1.49M Sell
6,119
-391
-6% -$94.9K 0.11% 174
2021
Q2
$1.35M Buy
6,510
+311
+5% +$64.3K 0.1% 184
2021
Q1
$1.17M Buy
6,199
+398
+7% +$74.9K 0.1% 183
2020
Q4
$954K Buy
5,801
+204
+4% +$33.5K 0.1% 186
2020
Q3
$698K Buy
5,597
+96
+2% +$12K 0.08% 211
2020
Q2
$534K Buy
5,501
+29
+0.5% +$2.82K 0.07% 239
2020
Q1
$492K Sell
5,472
-7,440
-58% -$669K 0.08% 218
2019
Q4
$1.91M Sell
12,912
-1,113
-8% -$165K 0.24% 92
2019
Q3
$1.69M Sell
14,025
-2,492
-15% -$300K 0.24% 96
2019
Q2
$2.23M Sell
16,517
-887
-5% -$120K 0.34% 66
2019
Q1
$2.27M Sell
17,404
-3,606
-17% -$470K 0.37% 66
2018
Q4
$2.62M Sell
21,010
-9,128
-30% -$1.14M 0.47% 43
2018
Q3
$4.19M Hold
30,138
0.7% 25
2018
Q2
$3.09M Sell
30,138
-156
-0.5% -$16K 0.54% 40
2018
Q1
$2.94M Sell
30,294
-2,478
-8% -$240K 0.54% 42
2017
Q4
$2.88M Buy
32,772
+1,967
+6% +$173K 0.49% 61
2017
Q3
$2.45M Sell
30,805
-184
-0.6% -$14.6K 0.46% 60
2017
Q2
$2.7M Sell
30,989
-1,439
-4% -$125K 0.41% 64
2017
Q1
$2.89M Buy
32,428
+887
+3% +$78.9K 0.45% 51
2016
Q4
$2.34M Buy
31,541
+8,456
+37% +$626K 0.41% 62
2016
Q3
$1.75M Buy
+23,085
New +$1.75M 0.32% 84